Analytical Research and Development, MRL, Merck & Co., Inc, Rahway, NJ, 07065, USA.
Anal Bioanal Chem. 2020 Apr;412(11):2655-2663. doi: 10.1007/s00216-020-02498-8. Epub 2020 Mar 4.
The analysis of complex mixtures of closely related species is quickly becoming a bottleneck in the development of new drug substances, reflecting the ever-increasing complexity of both fundamental biology and the therapeutics used to treat disease. Two-dimensional liquid chromatography (2D-LC) is emerging as a powerful tool to achieve substantial improvements in peak capacity and selectivity. However, 2D-LC suffers from several limitations, including the lack of automated multicolumn setups capable of combining multiple columns in both dimensions. Herein, we report an investigation into the development and implementation of a customized online comprehensive multicolumn 2D-LC-DAD-MS setup for screening and method development purposes, as well as analysis of multicomponent biopharmaceutical mixtures. In this study, excellent chromatographic performance in terms of selectivity, peak shape, and reproducibility were achieved by combining reversed-phase (RP), strong cation exchange (SCX), strong anion exchange (SAX), and size exclusion chromatography (SEC) using sub-2-μm columns in the first dimension in conjunction with several 3.0 mm × 50 mm RP columns packed with sub-3-μm fully porous particles in the second dimension. Multiple combinations of separation modes coupled to UV and MS detection are applied to the LC × LC analysis of a protein standard mixture, intended to be representative of protein drug substances. The results reported in this study demonstrate that our automated online multicolumn 2D-LC-DAD-MS workflow can be a powerful tool for comprehensive chromatographic column screening that enables the semi-automated development of 2D-LC methods, offering the ability to streamline full visualization of sample composition for an unknown complex mixture while maximizing chromatographic orthogonality. Graphical Abstract.
复杂的密切相关物种混合物的分析正迅速成为新药物物质开发的瓶颈,反映了基础生物学和用于治疗疾病的疗法的复杂性不断增加。二维液相色谱(2D-LC)正成为提高峰容量和选择性的有力工具。然而,2D-LC 存在几个局限性,包括缺乏能够在两个维度上组合多个柱子的自动化多柱设置。在此,我们报告了一项关于开发和实施定制在线综合多柱二维 LC-DAD-MS 系统的研究,该系统用于筛选和方法开发目的,以及分析多组分生物制药混合物。在这项研究中,通过在第一维中使用亚 2-μm 柱结合反相(RP)、强阳离子交换(SCX)、强阴离子交换(SAX)和尺寸排阻色谱(SEC),结合第二维中的几个 3.0mm×50mm 的 RP 柱,实现了出色的色谱性能,包括选择性、峰形和重现性。使用亚 3-μm 全多孔颗粒填充。将多种分离模式与 UV 和 MS 检测相结合,应用于蛋白质标准混合物的 LC×LC 分析,旨在代表蛋白质药物物质。本研究报告的结果表明,我们的自动化在线多柱 2D-LC-DAD-MS 工作流程可以成为一种强大的工具,用于全面的色谱柱筛选,从而能够半自动地开发 2D-LC 方法,提供对未知复杂混合物的全面可视化能力,同时最大限度地提高色谱正交性。